Advertisement
Advertisement
U.S. markets open in 7 hours 19 minutes
Advertisement
Advertisement
Advertisement
Advertisement

Artelo Biosciences, Inc. (ARTL)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
2.5100-0.0700 (-2.71%)
At close: 03:59PM EST
2.4800 -0.03 (-1.20%)
After hours: 06:18PM EST
Advertisement
Full screen
Loading interactive chart...
  • GlobeNewswire

    Artelo Biosciences Reports Third Quarter 2022 Financial Results and Provides Business Update

    Enrollment of Phase 2a CAReS Study Expected to Commence Near Year-End $19.5 Million in Cash and Investments as of September 30, 2022 SOLANA BEACH, Calif., Nov. 08, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today reported financial and operating results for the three months ended September 30, 2022 an

  • Newsfile

    Artelo Biosciences to Present at The LD Micro Main Event XV

    Solana Beach, California--(Newsfile Corp. - October 18, 2022) - Artelo Biosciences, Inc. (NASDAQ: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that Gregory D. Gorgas, Chief Executive Officer of Artelo, will be presenting at the 15th annual LD Micro Main Event being held at the Luxe Sunset Boulevard Hotel in Los Angeles, California. Presentation

  • GlobeNewswire

    Artelo Biosciences to Present at the 2022 Ladenburg Thalmann Healthcare Conference on September 29th

    SOLANA BEACH, Calif., Sept. 22, 2022 (GLOBE NEWSWIRE) -- Artelo Biosciences, Inc. (Nasdaq: ARTL), a clinical-stage pharmaceutical company focused on modulating lipid-signaling pathways to develop treatments for people living with cancer, pain, and neurological conditions, today announced that it will be presenting at the 2022 Ladenburg Thalmann Healthcare Conference being held on September 29, 2022 at the Sofitel Hotel in New York City. Gregory D. Gorgas, Chief Executive Officer of Artelo, is sc

Advertisement
Advertisement